Pfizer set to buy Allergan for more than $150 billion - sources

(Reuters) - Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, making it the healthcare sector's largest deal ever, according to people familiar with the matter.